Augmedix, Inc. (AUGX)

Market Cap	154.99M
Revenue (ttm)	44.86M
Net Income (ttm)	-19.17M
Shares Out	48.74M
EPS (ttm)	-0.44
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	221,719
Open	3.490
Previous Close	3.450
Day's Range	3.180 - 3.600
52-Week Range	1.750 - 6.250
Beta	-0.13
Analysts	Strong Buy
Price Target	5.38 (+69.18%)
Earnings Date	May 10, 2024

About AUGX

Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live that provides synchronous medical note documentation and point of care support; Augmedix Go Assist that offers asynchronous medical documentation based upon previously recorded visits; Augmedix Prep that provides patient demographics, past medical history, medication changes and other points from the patient's health record; and Augmedix Go, an autonomous, ambient AI mobile software applicatio...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2013
• Employees: 1,430
• Stock Exchange: NASDAQ
• Ticker Symbol: AUGX

Financial Performance

In 2023, Augmedix's revenue was $44.86 million, an increase of 45.01% compared to the previous year's $30.93 million. Losses were -$19.17 million, -21.59% less than in 2022.

Analyst Forecast

According to 4 analysts, the average rating for AUGX stock is "Strong Buy." The 12-month stock price forecast is $5.38, which is an increase of 69.18% from the latest price.

Price Target

$5.38

(69.18% upside)

Analyst Consensus: Strong Buy